Further analysis of the clinical data of ccRCC patients showed that ADAM12 expression was correlated with the tumor grade, T stage, M stage, and N stage of ccRCC patients, and high ADAM12 expression was found to be an independent factor associated with shorter survival in univariate and multivariate analyses. This evidence concerns the gene ADAM12 and neoplasm.